Hope in quest for gonorrhoea vaccination
July 11, 2017Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination
Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …
Ipsen secures NICE approval for multi-targeting kidney cancer therapy
July 11, 2017Manufacturing and Production, Sales and Marketing Cabometyx, Kidney cancer, NICE
Ipsen has announced that its therapy Cabometyx (cabozantinib) has been given approval by NICE for the treatment of advanced renal …
ABPI launches legal action to overturn £20m price cap
July 11, 2017Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, NHS England, NICE
When NICE announced in March that it would impose a £20 million per year cap on the price of drugs, …
Brain tumours to be used to manufacture stem cells
July 10, 2017Manufacturing and Production, Research and Development Censo Biotechnologies, University of Leeds
Censo Biotechnologies has announced that it will collaborate with the University of Leeds to use the latest stem cell technology …
New director of CDC courts controversy from all angles
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US
It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …
Revealing the missing evidence: Randomised real-life studies in basal insulin therapy
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, diabetes, real world data
Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance of …
Endo withdraws product as FDA secures step in opioid crisis fightback
July 10, 2017Sales and Marketing Endo pharmaceuticals, FDA, Opana ER
The FDA took the unusual step to ask Endo Pharmaceutical to voluntarily withdraw its opioid painkiller, Opana ER, from the …
Problematic facility inspection puts Biocon’s biosimilar EU approvals on hold
July 10, 2017Manufacturing and Production, Sales and Marketing Biocon, India, biosimilars
Indian firm Biocon has been hit by regulator criticism which has forced its European biosimilar programme on hold following a …
Shire and Roche haemophilia spat spills into court
July 10, 2017Sales and Marketing Roche, Shire, haemophilia
Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …
European pharma pulls together to ensure ‘minimal disruption’ from Brexit
July 10, 2017Research and Development, Sales and Marketing EMA, Europe, UK
As a consequence of the triggering of Article 50 and the UK’s exit from the EU, the EMA – currently …
FDA gives go-ahead to first sickle cell treatment in 20 years
July 10, 2017Sales and Marketing Emmaus Medical, L-glutamine, sickle cell disease
Emmaus Medical has been handed approval for the first new treatment for sickle cell disease in two decades. The active …
AstraZeneca appoint new MD for India
July 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, India
AstraZeneca announced a new Managing Director for AstraZeneca Pharma India, with Gagan Singh Bedi beginning the role on 3 July. …
Oral sex creating super-gonorrhoea
July 7, 2017Research and Development antibiotic resistance, gonorrhoea
The WHO has announced that data from across 77 different countries show that the sexually-transmitted infection (STI) gonorrhoea is becoming …
Top Ten most popular articles on Pharmafile.com this week
July 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing most read articles, most read news, top ten
It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Brexit …
Celgene plays catch up with $1.4 billion immunotherapy deal
July 7, 2017Medical Communications, Sales and Marketing BeiGene, Celgene, immunotherapy, pd-1
Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …
Top 50 Selling Products in the World by 2022
July 6, 2017Medical Communications
This article was originally published in Pharmafile Spring 2017.Opdivo and Revlimid to compete for the top spot in 2022, while …
New data shows pharma has not cut back on controversial payments to physicians
July 6, 2017Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant
Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …
FDA shutters MSD’s Keytruda combination trials in myeloma
July 6, 2017Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1
Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …
Oxford BioMedica in $100 million manufacturing deal with Novartis
July 6, 2017Manufacturing and Production, Sales and Marketing Novartis, Oxford BioMedica
Oxford BioMedica has announced that it has signed a contract with Novartis to supply the company with materials in a …
Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland
July 6, 2017Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada
Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
